Mogrify and Astellas align to tackle hearing loss
Cambridge, UK based Mogrify Limited is teaming up with Japan’s Astellas Pharma in targeted research aimed at addressing sensorineural hearing loss.
Archives for July 5, 2022
CureVac files patent infringement lawsuit against BioNTech over COVID-19 vaccine mRNA tech
CureVac has filed a lawsuit in a German regional court against BioNTech SE: seeking ‘fair compensation for infringement… of CureVac’s intellectual property rights’ regarding tech used in the manufacture of the Pfizer/BioNTech COVID-19 vaccine. BioNTech,...
AstraZeneca to buy blood cancer focused biotech in deal valued at up to $1.27bn
AstraZeneca is to acquire US-based blood cancer specialist, TeneoTwo, in a deal worth around US$1.27bn.
Hired and retired: New appointments in the biopharma industry
Pfizer, Valneva and CureVac are all welcoming new faces to top jobs.